Triomics is an oncology AI company building the infrastructure that turns complex, longitudinal cancer records into structured, explainable intelligence. The company's platform supports patient trial matching, pre-visit chart prep, and oncology data abstraction, helping care teams, research teams, and health systems act faster on the information already in the chart.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
05/28/26	$22,000,000	Series B	Battery Ventures Lightspeed Venture Partners Nexus Venture Partners Oncology Ventures Precision Health Informatics Y Combinator	undisclosed